Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to Annual General Meeting of Metsä Board Corporation on 28 March 2019 at 3 p.m.

Metsä Board Corporation Notice to Annual General Meeting, 7 February 2019 at 12.15 EETNotice is given to the shareholders of Metsä Board Corporation to the Annual General Meeting to be held on Thursday 28 March 2019 at 3.00 p.m. at the Finlandia Hall, Congress Wing, Hall A, at Mannerheimintie 13e (M1), Helsinki. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 2.00 p.m. A. Matters on the agenda of the General Meeting The following matters will be considered at the General Meeting: 1. Opening of the meeting

European High Growth Opportunities Securitization Fund has requested its sixth conversion of notes

In accordance with the financial agreement announced by EcoRub through the press release of October 8th, 2018 EHGOSF has requested conversion of twentyfour notes. All notes are then converted.The first tranche was for 5 million SEK and divided into fifty notes. Twentysix of these notes have earliar been converted. Twentyfour notes will now be converted into shares.  All notes connected to the first tranche are then converted. The value of these notes are 2 400 000 SEK. The conversion price for the first trance is 95 % of the lowest closing VWAP of the shares during a period of fifteen

Invitation to presentation of Coor’s 2018 Year End Report on February 21, 2019

Coor Service Management will be publishing its Full Year Report for 2018 on February, 21, at 07:30 CET. Accordingly, we’re inviting investors, analysts and media to a webcast (in English) on February, 21, at 09:30 CET, where Coor’s President and CEO Mikael Stöhr together with CFO and IR Director Olof Stålnacke will present and comment on the Interim Report.To participate in the webcast, please register via the following link: http://event.on24.com/wcc/r/1918864-1/D3208CC9F866DEB4948E1F771E17520B?partnerref=rss-events prior to the meeting. If you would like to listen to the

embedded world 2019: IAR Systems to showcase offering for IoT security, automotive functional safety and RISC-V

Uppsala, Sweden–February 7, 2019–At embedded world 2019, IAR Systems®, the future-proof supplier of software tools and services for embedded development, will present its ground-breaking technology for IoT security, developed with its sister company Secure Thingz, a global domain expert in device security, embedded systems and lifecycle management. In addition, the company will show its strengthened functional safety offering for automotive, and a preview of upcoming complete tools for RISC-V. The novelties are being presented as demos at IAR Systems (hall 4, booth 4-216) plus, like every

Metsä Board’s comparable operating result in 2018 was EUR 252 million

Financial statements bulletin for 1 January – 31 December 2018, 7 February 2019 at 12:00 noonJanuary–December 2018 (1–12/2017) • Sales were EUR 1,944.1 million (1,848.6). • Comparable operating result was EUR 251.9 million (193.5), or 13.0% (10.5%) of sales. Operating result was EUR 246.3 million (207.1). • Comparable earnings per share were EUR 0.58 (0.39), and earnings per share were EUR 0.57 (0.42). • Comparable return on capital employed was 14.4% (11.2%). October–December 2018 (7–9/2018) • Sales were EUR 458.0 million (475.1). • Comparable operating result was EUR

Cxense ASA - Extraordinary general meeting held

Reference is made to previous stock exchange announcements from Cxense ASA (the “Company”) regarding a contemplated underwritten rights issue of NOK 90 million (the “Rights Issue”).  An extraordinary general meeting was held in the Company today, 7 February 2019, in which it was resolved to carry out the Rights Issue. Minutes from the general meeting is enclosed hereto. The terms and conditions of the Rights Issue will be further described in a prospectus to be published prior to launch of the subscription period in the Rights Issue. The subscription period is expected to commence at 09:

1.8 million flew with SAS during January

The number of passengers traveling with SAS's scheduled traffic increased slightly compared to January 2018. At the same time, the passenger load factor and unit revenue increased.Compared to January 2018, capacity was unchanged while the number of passengers increased, leading to a 0.9 percentage point increase in the load factor to 64.9%. Currency adjusted unit revenue (PASK) increased with 3.6%. During the month, European/Intrascandinavian traffic fell slightly while Domestic and Intercontinental increased. ”Thanks to continued seasonal adjustments, both unit revenue as well as the

Outokumpu – Notice to the Annual General Meeting

Outokumpu OyjStock exchange releaseFebruary 7, 2019 at 12.00 pm EET Outokumpu – Notice to the Annual General Meeting Notice is given to the shareholders of Outokumpu Oyj to the Annual General Meeting to be held on Wednesday, March 27, 2019 at 1.00 pm EET at Finlandia Hall, Congress Wing, address: Mannerheimintie 13 e, 00100 Helsinki, Finland, entrances M1 and K1. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 12.00 pm EET. A.  Agenda of the Annual General Meeting At the Annual General Meeting, the

Year-end report 2018

Summary January-December 2018· Rental income increased to SEK 2,607 million (2,363). · Profit from property management increased to SEK 1,443 million (1,314). · Changes in value of properties amounted to SEK 2,060 million (1,682) and changes in value of financial instruments to SEK 91 million (135). · Profit after tax for the period increased to SEK 3,092 million (2,591). · Market value of investment properties amounted to SEK 46,236 million (38,883). · During the period, 29 properties (27) were acquired for SEK 3,135 million (2,668) and 10 properties (36) were divested for

Pileseptin gel is now available for sale at Apotek365

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin in the Nordic market, reports that Pileseptin gel is now available at Apotek365. The product will also be available on Meds.se shortly. Pileseptin in spray form is already available on the market since January. "We are happy to have our first non-prescription product on the market in both its forms and work to establish a deal with several other sales channels in the future," comments Igor Lokot, CEO at Double Bond Pharmaceutical and Drugsson AB, - We continue also to look for new, sought-after products that

MTG’s Extraordinary General Meeting

The Extraordinary General Meeting (EGM) of Modern Times Group MTG AB (MTG) shareholders, which was held today in Stockholm, resolved to distribute all of the shares in Nordic Entertainment Group AB (NENT Group) to MTG’s shareholders.The EGM approved the Board of Directors’ proposal to distribute all of the shares in the wholly owned subsidiary NENT Group, which comprises MTG’s Nordic Entertainment and Studios business segments. Holders of one (1) MTG class A share will receive one (1) NENT Group class A share and holders of one (1) MTG class B share will receive one (1) NENT Group class B

Railcare signs strategic framework agreement with Trafikverket

Railcare have signed a framework agreement with Trafikverket with regards to the track work required throughout Sweden. The agreement period is for two years with an option to extend for another two. The framework agreement is strategically important for Railcare as the company can optimise the utilisation of its Railvac machines throughout planned customer projects for a long period. The framework agreement also includes the preliminary work associated with the upcoming track removal work, which is included in Trafikverket’s announced plans. In conjunction with the contract, Railcare

Article in BioStock: Follicum have developed a creamlike formulation for treatment of hair loss

BioStock published an article about Follicum’s topical formulation on 7 February 2019 in Swedish . The article is here translated into English. Follicum develops FOL-005 to stimulate hair growth. The peptide-based candidate has recently undergone a phase IIa-study and the company was able to present positive top-line results during the fall. This summer a topical formulation of FOL-005 was completed and the company have now presented results demonstrating that treatment with the

Invitation to presentation of BioArctic’s Full Year Report 2018 on February 14, 2019

Stockholm, Sweden, February 7, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Full Year Report for the period January – December 2018 on Thursday,February 14, 2019 at 08:00 a.m. CET. BioArctic invites to an audiocast with teleconference (in English) for investors, analysts and media on February 14, at 09:30 – 10:30 a.m. CET. Gunilla Osswald, CEO, and Jan Mattsson, CFO, to present BioArctic and comment on the Full Year Report for the period January – December 2018 followed by a Q&A-session. Sweden: + 46 8 505 583 53Denmark: + 45 781 501 08

Ericsson launches critical communications broadband networks offering

· Industry digitalization and modernization of the land mobile radio (LMR) communications is driving demand for critical broadband network solutions · New portfolio comprises Critical Network Capabilities, Critical Broadband Applications, and Flexible Deployments for Private Networks · Enables service providers to meet critical communication needs in industries such as public safety, energy and utilities, transportation, and manufacturingEricsson (NASDAQ: ERIC) has launched its critical communications broadband portfolio for service providers. This will enable service providers to

Sobi presents comprehensive study data on extended half-life haemophilia treatments at EAHAD

Sobi™  will present data at the European Association of Haemophilia and Allied Disorders (EAHAD) conference in Prague, Czech Republic, 6-8 February 2019, showing evidence on the safety, efficacy and long-term benefits of its extended half-life products for the treatment of haemophilia. The studies that will be presented support Sobi’s commitment to develop a treatment paradigm that expand the possibilities and transform life for people with haemophilia. Sobi and our collaboration partner Sanofi will provide interim data on the incidence of inhibitors in previously

Aspire Global’s Year-End Report 2018 to be Published on February 14th 2019 – Invitation For Audiocast

On February 14th, 2019 Aspire Global will be announcing the year-end report for 2018. On that same day at 10:00 am (CET) investors, analysts and journalists are welcome to participate in an audiocast with teleconference where the company CEO, Tsachi Maimon, and CFO, Motti Gil, will be presenting the report, followed by a Q&A-session.The presentation will be held in English and is audiocasted live through the following link: https://tv.streamfabriken.com/aspire-global-q4-2018  The meeting, including the Q&A-session, is also available by calling one of the following telephone numbers:

STENOCARE A/S achieved its objective of delivering 2,100 treatments during September to December 2018

STENOCARE A/S (“STENOCARE”) today announces that the company has delivered 2,200 bottles of medical cannabis oil during September to December 2018 and hence met and exceeded its objective of supplying approx. 2,100 treatments to Danish patients during the period. This objective was communicated in the memorandum that was established in connection to the company’s IPO in September/October 2018.On the 30th of November 2018, STENOCARE announced that the company had received its second batch of medical cannabis oil products, which put STENOCARE on track to meet its objective of supplying approx.

Invitation to conference call, February 14 at 2:00 pm CET

Studsvik AB presents its Year-end Report for 2018 and hereby invites media and analysts to a conference call held in English on Thursday, February 14 at 2:00 pm CET.Studsvik’s Year-end Report for 2018 will be distributed at approximately 1.00 pm CET, February 14. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 2:00 pm CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q4 2018. Conference ID is: 4485226  Description Local Call

NextCell´s CEO invited speaker at National conference on Clinical Studies

NextCell Pharma AB ("NXTCL") announces that its CEO, Mathias Svahn PhD has been invited to speak at the 2019 National Conference on Clinical Studies.The conference, which is held in Malmö and arranged by the national initiative Clinical Studies Sweden, a collaboration between Vetenskapsrådet (Swedish Research Council) and Sweden´s six healthcare regions, brings together researchers, politicians, and others who are active in the Life Science area. The scope of the event is knowledge exchange and networking, with the topic for the year being “The Value of Clinical studies”. Examples of issues

Pia Renaudin joins as new CEO at Senzime

Press release: Uppsala, February 7th, 2019.Pia Renaudin assumes her position as the new CEO of Senzime AB (publ).Senzime announced on the 19th of November 2018 the appointment of Pia Renaudin as new CEO. Pia has of today assumed her position and succeeds Catrin Molund in her capacity as acting CEO. For further information, please contact:  Pia Renaudin, CEO of Senzime AB                                                                                                                  Tel: +46 (0)70-813 34 17, email: pia.renaudin@senzime.com         TO THE EDITORS About

myFC receives funding from Vinnova for the continued development of fuel cells

Horizon 2020 is the world's largest research and innovation program, and it is led by the European Commission. The program provides grants for groundbreaking, high-tech innovation projects. myFC has now, in fierce competition, passed the first phase for further funding through Horizon 2020 and has been awarded half a million SEK by Vinnova.It is myFC’s work to develop fuel cell technology and the associated fossil-free fuel for integration into a smartphone that has been rewarded. In the initial expert evaluation, myFC was awarded 13.5 out of 15 points – only a few percent of the submitted

Nomination Board’s proposals to Nordea’s Annual General Meeting 2019

Björn Wahlroos has informed the Nomination Board of his intention to step down from the Board of Directors of Nordea Bank Abp. Torbjörn Magnusson is proposed to replace him as Chair of the Board of Directors. The Nomination Board of Nordea Bank Abp announces today its proposals to Nordea’s Annual General Meeting on 28 March 2019. The Nordea Bank Abp Board of Directors will include the proposals in the notice to the Annual General Meeting to be published later in February 2019. Election of members and Chair of the Board of Directors The Nomination Board proposes, for a period until

There are no items matching the current filter
There are no more items matching the current filter
Back to top